PHILADELPHIA, June 2 /PRNewswire-FirstCall/ -- Aberdeen Israel Fund, Inc. (the "Fund") (NYSE AMEX: ISL), a closed-end equity fund, announced today its performance data and portfolio composition as of April 30, 2010.
The Fund's total returns for various periods through April 30, 2010 are provided below. (All figures are based on distributions reinvested at the dividend reinvestment price and are stated net-of-fees):
NAV Total Return %
Market Price Total Return %
On April 30, 2010, the Fund's net assets amounted to US$72.9 million and the Fund's NAV per share was $17.07.
As of April 30, 2010, the portfolio was invested as follows:
The Fund's ten largest equity holdings as of April 30, 2010, representing 72.5% of net assets, were:
Teva Pharmaceutical Industries Limited
Check Point Software Technologies
Bezeq The Israeli Telecommunication Corporation Limited
United Mizrahi Bank Limited
Israel Chemicals Limited
Harel Insurance Investments & Financial Services
Bank Hapoalim BM
Bank Leumi Le-Israel BM
Aberdeen Asset Management Inc. has prepared this report based on information sources believed to be accurate and reliable. However, the figures are unaudited and neither the Fund, Aberdeen Asset Management Investment Services Limited (the Investment Adviser), nor any other person guarantees their accuracy. Investors should seek their own professional advice and should consider the investment objectives, risks, charges and expenses before acting on this information. Aberdeen is a U.S. registered service mark of Aberdeen Asset Management PLC.
Total return figures with distributions reinvested at the dividend reinvestment price are stated net-of-fees and represents past performance. Past performance is not indicative of future results, current performance may be higher or lower. Holdings are subject to change and are provided for informational purposes only and should not be deemed as a recommendation to buy or sell the securities shown. Inception date October 29, 1992.
If you wish to receive this information electronically, please contact: InvestorRelations@aberdeen-asset.com
SOURCE Aberdeen Israel Fund, Inc.